The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer

Published:2010-03 Issue:3 Volume:57 Page:410-429
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Gontero Paolo,Bohle Andreas,Malmstrom Per-Uno,O’Donnell Michael A.,Oderda Marco,Sylvester Richard,Witjes Fred

Publisher

Elsevier BV

Subject

Urology

Reference92 articles.

1. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement;Brandau;Biomed Pharmacother,2007

2. Methodological bases for systematic reviews;Galfano;J Androl Sci,2008

3. Phillips B, Ball C, Sackett D, et al. Levels of evidence. Oxford Centre for Evidence-based Medicine Web site. http://www.cebm.net/levels_of_evidence.asp. Updated March 2009.

4. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story;Herr;J Urol,2008

5. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why is it necessary to produce a BCG strain in Spain?;Actas Urológicas Españolas (English Edition);2024-09

2. ¿Por qué es necesario tener una cepa de BCG fabricada en España?;Actas Urológicas Españolas;2024-09

3. Genetic engineering of Salmonella spp. for novel vaccine strategies and therapeutics;EcoSal Plus;2024-07-18

4. Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy;Nature Communications;2024-05-21

5. Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia;Frontiers in Urology;2024-02-14